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The collapse of thymic stromal cell microenviron-
ment with age and resultant inability of the thymus
to produce naive T cells contributes to lower
immune-surveillance in the elderly. Here we show
that age-related increase in ‘lipotoxic danger signals’
such as free cholesterol (FC) and ceramides, leads to
thymic caspase-1 activation via the Nlrp3 inflamma-
some. Elimination of Nlrp3 and Asc, a critical adaptor
required for inflammasome assembly, reduces age-
related thymic atrophy and results in an increase in
cortical thymic epithelial cells, T cell progenitors
and maintenance of T cell repertoire diversity. Using
a mouse model of irradiation and hematopoietic
stem cell transplantation (HSCT), we show that dele-
tion of the Nlrp3 inflammasome accelerates T cell
reconstitution and immune recovery in middle-aged
animals. Collectively, these data demonstrate that
lowering inflammasome-dependent caspase-1 acti-
vation increases thymic lymphopoiesis and suggest
that Nlrp3 inflammasome inhibitors may aid the
re-establishment of a diverse T cell repertoire in
middle-aged or elderly patients undergoing HSCT.INTRODUCTION
There are 39.6 million individuals aged 65 years or older in the
US, a number expected to increase to approximately 72 million
by 2030 (CDC, 2003). In addition, the number of persons
aged R80 years is expected to increase from 9.3 million in
2000 to 19.5 million in 2030 (CDC, 2003). Intriguingly, thymic
aging precedes that of several other organs and is a central
feature and precursor of age-related deterioration in immune
competence that appears in later life (Dorshkind et al., 2009;
Chidgey et al., 2007).56 Cell Reports 1, 56–68, January 26, 2012 ª2012 The AuthorsIn metabolically healthy individuals, by the age of 45 years,
approximately 75% of the thymic microenvironment is
composed of lipid-containing cells (Dixit, 2010). The early
collapse of the thymic microenvironment or age-related thymic
involution is characterized by a loss of developing T cells,
thymic epithelial cells (TECs) (Chidgey et al., 2007), an increase
in thymic fibroblasts (Yang et al., 2009), and an emergence of
lipid-laden cells (Dixit, 2010) via mechanisms that are still largely
unclear. When the thymic lymphopoiesis or the thymic export of
naive T cells plummets, the total peripheral T cell pool is main-
tained through homeostatic expansion of preexisting effector
memory (E/M) T cells at the expense of naive T cells in
a thymus-independent manner (Goronzy and Weyand, 2005).
The consequent restriction of T cell diversity in aging is associ-
ated with an increased risk and severity of emerging infections,
certain cancers, and vaccination failures in the elderly (Maue
et al., 2009). Furthermore, age-related thymic involution is
a significant impediment to effective T cell reconstitution in
middle-aged patients undergoing hematopoietic stem cell trans-
plantations (HSCT) (Holland and van den Brink, 2009). Therefore,
the ability to enhance thymic lymphopoiesis is thought to be
central to the rejuvenation of T cell-mediated immune surveil-
lance in the elderly (Dorshkind et al., 2009; Chidgey et al.,
2007; Holland and van den Brink, 2009; Holla¨nder et al., 2010).
While reduction of stromal cell-derived intrathymic growth
factors and alterations in extrinsic factors, such as circulating
neuroendocrine hormones, play an important role in thymic
involution, little is known about molecular triggers that cause
thymic aging (Dorshkind et al., 2009; Dixit, 2010). Our prior
studies have shown that partial reversal of age-related thymic
involution by ghrelin, an agonist of growth hormone secreta-
gogue receptor (GHSR), is associated with a reduction in the
proinflammatory cytokine IL-1b (Dixit et al.,. 2004; Dixit et al.,
2007). Consistent with the potential role of high levels of IL-1b
in promoting thymic dysfunction, administration of IL-1b also
induces marked thymic atrophy in mice (Morrissey et al.,
1988a, Morrissey et al., 1988b). However, it remains unclear
whether the specific mechanisms that initiate the activation of
IL-1b cause age-related thymic involution.
The cleavage of proIL-1b and proIL-18 into bioactive cytokines
is predominantly dependent on caspase-1 (Kuida et al., 1995; Di-
narello, 2011). The activation of caspase-1 zymogen into enzy-
matically active p20 and p10 heterodimers is, in turn, controlled
by cytosolic multiprotein complexes called ‘‘inflammasomes’’
(Martinon et al., 2002; Lamkanfi and Dixit, 2009). The Nlrp3
(nucleotide-binding domain, leucine-rich–containing family,
pyrin domain–containing-3, also called Nalp3 and cryopyrin)
inflammasome is formed via protein-protein interactions
involving the pyrin domains of Nlrp3 and Asc (Mariathasan
et al., 2004; Sutterwala et al., 2006; Martinon et al., 2009). The
Asc protein serves as a key adaptor and binds with pro-cas-
pase1 via CARD-CARD (caspase activation recruitment domain)
interactions (Kanneganti et al., 2007; Latz, 2010). The Nlrp3
inflammasome can be activated by diverse ‘‘danger-associated
molecular patterns’’ (DAMPs) derived from damaged cells and
organelles, and it induces inflammation by secretion of IL-1b
and IL-18 (Zhou et al., 2010; Duewell et al., 2010; Mariathasan
et al., 2006). It is, however, unknown whether such inflamma-
some-mediated sensing has a causal role in aging-associated
defects in thymic lymphopoiesis.
In our recent studies, we showed that deletion of Nlrp3 re-
sulted in an unexpected increase in the number of naive T cells
in nonlymphoid organs such as subcutaneous adipose tissue
(Vandanmagsar et al., 2011). These findings led us to hypothe-
size that the Nlrp3 inflammasome causes thymic involution by
sensing an age-associated increase in intrathymic ‘‘lipotoxic
danger signals’’ and that dampening of Nlrp3 inflammasome
activation may enhance naive T cell production by the thymus.
Our current findings establish that Nlrp3 inflammasome-medi-
ated sensing of age-related DAMPs, such as free cholesterol
(FC) and ceramides within the thymic microenvironment, leads
to caspase-1 activation. We show that lowering Nlrp3 inflamma-
some activity slows thymic aging and protects from subsequent
T cell senescence.
RESULTS
Nlrp3 Inflammasome Senses Aging-Associated
Lipotoxic ‘‘Danger Signals’’ in Mouse Thymus
Given that aging is associated with increases in several ‘‘danger
signals’’ associated with a chronic proinflammatory state, our
initial studies examined whether caspase-1 processing is asso-
ciated with thymic aging. We found a marked age-dependent,
progressive increase in autocatalytic processing of inactive pro-
caspase-1 into the active p20 caspase-1 heterodimer in thymus.
This increase was apparent by 5–6 months of age and highest in
2-year-old mice (Figure 1A; Figure S1A available online). Our
data revealed that Nlrp3 and Il-1b are highly expressed in thymic
myeloid cells (TMCs; CD45+CD11c+) and have low expression in
thymocytes (CD45+CD11c) and thymic stromal cells (TSCs;
CD45CD11c) (Figures 1B and 1C). Interestingly, the TSCs
had the highest expression of Il-1R (Figure 1C). The Asc/Pycard
and Il-18 mRNA was expressed in all examined cell types (Fig-
ure 1B and Figure S1B).
Next, we investigated the age-related DAMPs that cause cas-
pase-1 activation. Interestingly, in contrast to young (1-month-
old) animals, middle-aged (12-month-old) mice had a significantincrease in thymic concentration of potentially cytotoxic FC
(Figure 1D). Surprisingly, the thymic cholesterol ester content
was reduced to undetectable levels with age (Figure S2A).
Immunostaining of thymic cryosections revealed that the
majority of FC staining in the aging thymus was localized to
CD11b+ thymic macrophages in the medullary region (Figure 1E
and Figure S2B). Interestingly, in the presence of elevated
intracellular FC, lipopolysaccharide (LPS)-primed bone-
marrow-derivedmacrophages (BMDMs) displayed autocatalytic
processing of caspase-1 (Figure 1F). The FC-induced caspase-1
cleavage and IL-1b secretion in BMDMs was abolished in
the absence of Nlrp3 (Figures 1G and 1H). Of note, this was
not due to differences in FC loading or cholesterol ester
content in the BMDMs of wild-type (WT) and Nlrp3/ mice
(Figure S2C).
Aging is also associated with an increase in ‘‘danger signals’’
such as extracellular ATP from dead cells or byproducts of fatty
acid metabolism, including ceramides, lipid peroxidation
product like 4- hydroxynonenal (4HNE), and advanced glycation
end (AGE) products (Wu et al., 2007; Ramasamy et al., 2005;
Mattson 2009; Tucker & Turcotte 2003). We found that extracel-
lular ATP and ceramides cause caspase-1 cleavage into enzy-
matically active p20 subunits, whereas AGE, 4HNE, and fatty
acids (such as palmitate, stearidonic acid [SDA], and docosa-
hexanoic acid [DHA]) did not cause caspase-1 activation in
macrophages (Figure 1I). Furthermore, the BMDMs deficient in
Asc were not activated by C2 and C6 ceramide-induced
caspase-1 cleavage (Figure 1J), demonstrating that the Nlrp3
inflammasome specifically senses ceramides as lipotoxic
‘‘danger signals.’’
Measurement of ceramides in the thymus by liquid chroma-
tography-tandem mass spectrometry (LC/MS/MS) revealed
that in comparison to that of 2-month-old animals, the total
ceramide content was significantly increased in aged thymi (Fig-
ure 1K). Interestingly, similar to FC, we detected increased
immunoreactivity for ceramides in the thymic medulla with
pronounced colocalization in thymic macrophages (CD11b+
and F4/80+; Figure 1L; Figures S2D and S2E). The intrathymic
delivery of C6 ceramide injection in young WT mice induces
strong caspase-1 activation in the thymus, which was substan-
tially reduced in the absence of Nlrp3 (Figure 1M). These data
suggest that increasing the ceramide content in the thymus
in vivo causes caspase-1 activation via the Nlrp3 inflamma-
some-dependent mechanism.
Nlrp3 Inflammasome Activation Promotes Age-Related
Thymic Involution
Next, we investigated whether the Nlrp3 inflammasome regu-
lates the age-related increase in caspase-1 activation. Our
data revealed that caspase-1 processing in thymi derived from
9-month-old mice is dependent on Nlrp3 inflammasome activa-
tion (Figure 2A). Furthermore, the caspase-1 activation in
18-month-old thymi was significantly attenuated in Nlrp3-defi-
cient mice (Figure 2B and Figure S3A). Consistent with these
data, in comparison to that of 18-month-old WTmice, IL-1b acti-
vation in thymi from Nlrp3-deficient mice was also considerably
reduced (Figure 2C, Figure S3B). IL-1b levels in the plasma and
sera of agedWTmice were below the detection limit of the assayCell Reports 1, 56–68, January 26, 2012 ª2012 The Authors 57
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Figure 1. Thymic Aging Is Associated with the Inflammasome Activation
(A) Immunoblot analysis of caspase-1 in the thymus of C57/B6 mice from 1 month to 24 months of age. The experiment was repeated thrice from three different
cohorts of mice, and the data are expressed as fold change of active caspase-1 (p20) normalized to actin from a total of six mice per age point.
(B and C) The thymocytes (CD45+CD11c), thymic myeloid cells (CD45+CD11c+), and thymic stromal cells (CD45CD11c) from 1- and 9-month-old mice (n = 6
each, repeated twice) were sorted via FACS. The total RNA was used for real-time PCR analysis of Nlrp3, Asc, Il1r, and Il1b. The mRNA expression was
normalized to Gapdh and shown as relative expression (DDCt). Data are presented as mean ± SD, *p < 0.01.
(D) The FC levels in the thymi derived from 1- and 12-month-old (n = 6/group) C57/B6 mice were measured via gas liquid chromatography.
(E) The thymic cryosections from 24-month-old C57/B6 mice (n = 3) were immunostained with CD11b and filipin that binds to FC. The nuclei were counterstained
with propidium iodide (red). The confocal immunofluorescence analysis shows colocalization of macrophages with FC in the medullary area of the thymus.
(F) The LPS-primed BMDMs were loaded with methyl b-cyclodextrin-cholesterol (cholesterol concentration: 80 mg/ml), which increases FC levels in BMDM to
60 mg/mg protein (Figure S1E). The cells were exposed to LPS for 6 hr and to FC for 1 hr. The immunoblot analysis shows activated p20 form of caspase-1 in
FC-loaded LPS-primed cells.
(G) The immunoblot analysis of the p20 subunit of caspase-1 in BMDMs fromWT andNlrp3/mice exposed to LPS and loaded with FC as described above. The
two lanes represent two different BMDM culture experiments from pooled cells of a total of six WT and six Nlrp3 knockout mice.
(H) The IL-1b levels were determined by ELISA from supernatants of BMDMs derived from WT and Nlrp3/ mice and activated by LPS and FC.
(I) The immunoblotting for caspase-1 p20 in the LPS-primed BMDMs treated with ATP (5 mM), C2 ceramide (0.1 mM), C6 ceramide (0.1 mM), AGE (100 mg/ml),
BSA-conjugated palmitate (0.1 mM), SDA (0.1 mM), DHA (0.1 mM), and 4HNE (50 mg/ml).
(J) The immunoblot analysis of the p20 subunit of caspase-1 in BMDMs fromWT and Asc/mice primed with LPS and treated with ATP, ceramides, and 4HNE.
The results are representative of three different experiments.
(K) The total ceramide levels in thymi from 1-month-old and 23-month-old mice (n = 6/group) were measured via LC/MS/MS.
(L) The confocal immunofluorescence analysis of thymus labeledwith anti-ceramide antibody (green, Alex Fluor488), anti-CD11b (red, Alexa Fluor 594) antibodies
in 1- and 23-month-oldWTmice. Themajority of staining (colocalization of ceramides and CD11b is indicated by yellow) was localized in thymic medulla (m), with
little immune reactivity in thymic cortex (c). DAPI (blue) was used to counterstain the nuclei. Representative image from a total of four sections from three mice
each used for confocal immunofluorescence analysis is shown.
(M) The C6 ceramide (10 mg/Kg b.w.) was injected intra-thymically in WT and Nlrp3/ mice and thymi were collected after 1 hr for caspase-1 immunoblot
analysis. The control mice were intrathymically injected with vehicle (alcohol). The quantification of p20 caspase-1 immunoblot band intensities were analyzed
with ImageJ, and arbitrary units were normalized to actin and expressed as fold change. All data are presented as mean ± SEM, *p < 0.05.
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Figure 2. The Ablation of Nlrp3 Inflammasome Protects against Age-Related Thymic Involution
(A and B) The immunoblot analysis of caspase-1 activation in the thymus of WT and Nlrp3/ mice at (A) 9 months and (B) 18 months of age.
(C) Immmunblot analysis of IL-1b activation in the thymi of 18-month-old WT and Nlrp3/ mice.
(D) Representative images showing the thymic size of WT, Nlrp3/, and Asc/ mice at 1, 5, 18, and 23 months of age.
(E) Total thymocyte counts in WT andNlrp3/ and Asc/mice at indicated ages (n = 6–12/age group). The thymocyte counts from 1- and 5-month-old mice are
from one cohort of mice (n = 6/age group/strain). The data at each age point are analyzed from 2–3 cohorts (9-month-old from three cohorts, 18- and 23-month-
old from two cohorts) of mice sacrificed at least 6 months apart.
(F) Representative H&E-stained sections from 14-month-oldNlrp3/ and Asc/mice (n = 3–5). Loss of cortical regions (c) andmedullary areas (m) inWTmice is
prevented in Nlrp3/ and Asc/.
(G) The FFPE thymi of 14-month-old WT and Nlrp3/mice (n = 3/ group) stained with Masson’s trichome (light blue color indicates binding to collagen). The WT
mice display greater subcapsular fibrosis and an increase in ectopic adipocytes in comparison to age-matched Nlrp3/ mice.
(H) Representative H&E-stained FFPE thymic sections of 23-month-old WT and Nlrp3/ and Asc/mice (n = 4/group). In comparison to young (3-month-old)
WT controls, age-related thymic involution is evident in 23-month-old WT mice by loss of cortico-medullary junctions, complete loss of cortical regions, and
increase in thymic cysts and adipocytes.(data not shown), suggesting that intrathymic IL-1b and cas-
pase-1 activation impacts the thymic involution process.
To determine a definitive causal relationship between inflam-
masome activation and age-related thymic involution, we inves-
tigated thymic mass (Figure 2D) and thymic cellularity (Figure 2E)
in Nlrp3- and Asc-deficient mice aged 1, 5, 9, 18, and 23 months
and fed a normal-chowdiet. In comparison to youngWT animals,
neither Nlrp3- nor Asc-deficient mice displayed any difference in
thymic cellularity or thymic size (Figures 2D and 2E; Figure S4).
Concomitant with the timing and the degree of caspase-1 activa-
tion in the thymus (Figure 1A), the 5-, 9-, 18-, and 23-month-old
Nlrp3/ and Asc/ mice showed significant protection from
age-related decline in thymic mass and cellularity (Figures 2Dand 2E). The evaluation of body composition by nuclear
magnetic resonance (NMR) imaging revealed no differences in
normal-chow-fed WT, Nlrp3-deficient, and Asc-deficient mice
at 1, 9, 18, and 23 months of age (data not shown), suggesting
that changes in systemic adiposity do not account for the differ-
ences in the thymic involution.
The examination of thymic architecture revealed that, in
comparison to age-matched WT controls, 14- and 23-month-
old Nlrp3/ and Asc/ mice displayed remarkable preserva-
tion of cortical and medullary cellularity (Figure 2F). In
14-month-old WT mice, evidence of medullary fibrosis and
presence of ectopic adipocytes in subcapsular cortical zones
was clearly evident by hematoxylin and eosin (H&E) stainingCell Reports 1, 56–68, January 26, 2012 ª2012 The Authors 59
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Figure 3. Elimination of Nlrp3 Inflammasome Improves Thymic Stromal Microenvironment in Aging
(A) The thymic cells from 18-month-old WT,Nlrp3/, and Asc/mice were labeled with CD45, MHC-II, and Ly5.1 for the identification of medullary TEC (mTEC)
(CD45-MHCII+Ly5.1-) and cTEC (CD45MHCII+Ly5.1+) subsets. The expression of MHCII and Ly5.1 is analyzed in the CD45-negative population. The percentage
of gated cTEC cells is significantly (p < 0.05) increased in Nlrp3/ and Asc/ mice (n = 4-6/group).
(B) Thymic sections from 18-month-old WT and Asc/ animals were used to stain for keratin 8+ cortical TEC with anti-TROMA1 antibody, and medullary TECs
were identified by biotin-conjugated plant lectinUlex europaeus agglutinin 1 (UEA-1). Nuclei were counterstained with DAPI. In olderWTmice, mTEC staining was
localized on the periphery of medullary regions, whereas in Nlrp3/ mice, the medulla had diffuse UEA1 immuopositivity.
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(Figure 2F). In contrast, thymic sections of 14-month-old
Nlrp3/ and Asc/ mice revealed clearly defined cortico-
medullary junctions and an absence of adipogenic cells within
thymic zones (Figure 2F). The trichome staining revealed
a considerable increase in subcapsular fibrosis and ectopic
adipocytes in 14-month-old WT mice, whereas Nlrp3/ mice
had negligible subcapsular fibrosis and the majority of the extra-
cellular matrix (ECM) was localized to the well-defined medullary
regions (Figure 2G). By 23 months of age, mice showed
a collapse of thymic architecture that was more severe and
was noticeable by the loss of cortical areas, inversion of cor-
tico-medullary zones, the appearance of thymic cysts, and an
increase in thymic adipocytes (Figure 2H). Consistent with an
increase in thymic cellularity, the histological examinations re-
vealed that 23-month-old Nlrp3/ and Asc/ mice were
substantially protected from age-related thymic involution
(Figure 2H).
Deletion of the Nlrp3 Inflammasome Partially Protects
against Age-Related Decline of TECs
and T Cell Progenitors
The age-related reduction of TECs and T cell progenitors are the
major mechanisms that compromise naive T cell export from the
thymus (Dorshkind et al., 2009; Chidgey et al., 2007; Holland and
van den Brink, 2009). Consistent with increased inflammasome
activation in the aged thymus and high Il1r in enriched TECs,
we found that both Nlrp3/ and Asc/mice exhibited a signif-
icant increase in cortical TECs (cTECs) (CD45MHCII+Ly5.1+)
(Figure 3A), with no change in TEC frequencies at young ages
(data not shown). The confocal analyses revealed that
18-month-old Asc/ mice have increased immunostaining for
cTECs (Figure 3B). In addition, in comparison to those from
WT controls, the TECs from the thymi of 12-month-old Nlrp3/
mice expressed significantly higher levels of Il7 and Kitl (Kit
ligand, also called stem cell factor [SCF]) (Figure 3C). Consistent
with these data, the thymi of Nlrp3/ and Asc/ mice have
significantly higher expression of Il7, Il7R, and Kitl, suggesting
a superior thymic stromal microenvironment favoring enhanced
thymic lymphopoiesis (Figure 3D).
In comparison to WT mice, ablation of Nlrp3 inflammasome
components (Nlrp3 and Asc) in mice of all ages examined did
not affect the frequencies of CD4 single-positive (SP), CD8SP,
or double positive (DP) cells, suggesting no defects in T cell
development or in the number of T cell progenitors (data not
shown). Interestingly, the thymi of aged (23-month-old) Nlrp3/
mice had a significant increase in the earliest thymocyte progen-
itors (ETP; LinCD117+CD25) and double-negative (DN)2 cells
(LinCD117+CD25+) and no change in DN3 (LinCD117CD25+)
and DN4 (LinCD117CD25) T cell progenitors (Figures 4A
and 4B).
Thymic lymphopoiesis is dependent on homing of hemato-
poietic stem cells (HSCs) from the bone marrow to the thymus
(Bhandoola et al., 2007). We found that there was an age-depen-(C) The CD45EpCAM+ TECs from 12-month-oldWT andNlrp3/mice (n = 5/gro
cell factor [SCF]) by real-time PCR analysis.
(D) The IL-7, IL-7R, and SCF mRNA in thymi of 9- to 10-month-old WT, Nlrp3/,
mRNA expression was normalized to Gapdh and is shown as fold change DDCt.dent increase in inflammasome activation in bone marrow
(Figure 4C). In comparison to 23-month-old WT mice, the
age-matched Nlrp3/ animals displayed a significant in-
crease in lymphoid primed multipotent progenitors (LPMP:
LinSca1+Kit+Flt3+) in bone marrow and no change in the more
differentiated population of common lymphoid progenitors
(CLPs; Lin-Sca1+KitloCD127) (Figures 4D and 4E). In addition,
ablation of Nlrp3 did not alter the frequency of other lineages
tested, including granulocyte-macrophage progenitor (GMP),
common myeloid progenitor (CMP), and myelo-erythroid
progenitors (MEP) populations, in the bone marrow (data not
shown). Collectively, these data suggest that age-related Nlrp3
inflammasome activation may adversely impact thymic function
by affecting the TECs and T cell progenitors in the thymus and
bone marrow.
Inflammasome Activation during Aging Induces
Immunosenescence
Consistent with no difference in thymic cellularity in 1-month-old
mice, there was no change in naive CD4 and CD8 cell number
between young WT mice and the Nlrp3/ animals (Figure S5A).
Interestingly, as the effects of aging on the erosion of naive T cell
repertoire became evident in 9-month-old WT mice, the age-
matched Nlrp3/ mice displayed a significant increase in CD4
and CD8 naive T cells with lower E/M populations (Figure 5A).
Further analysis of 23-month-old Nlrp3/ and Asc/ mice re-
vealed a pronounced increase in naive T cells and a significant
protection from age-related preponderance in E/M cells
(Figure 5B).
Next, we quantified thymic T cell export by measurement of
T cell receptor rearrangement excision circles (TREC), which
are episomal byproducts of TCRd locus excision during thymic
TCRab rearrangement (Douek et al., 1998). Under most condi-
tions, TREC levels in the peripheral T cells directly correlate
with production of new T cells by the thymus (Sempowski
et al., 2002). In comparison to WT mice, there was a significant
increase in the number of TRECs in CD4 cells of 9- and
18-month-old Nlrp3-deficient mice (Figure 5D), suggesting
increased thymic lymphopoiesis.
We then investigated whether the increased thymic export in
Nlrp3/ mice is associated with reduced T cell senescence,
specifically lower antigen-specific T cell proliferation and the
restriction of TCR diversity. In contrast to T cells from aged WT
mice, the T cells from 18-month-old (Figure S5B) and
23- month-old Nlrp3/ mice exhibited significant increases in
proliferation and Il2 expression upon TCR ligation (Figures 5E
and 5F). We studied the TCR diversity of peripheral CD4+
T cells by measuring the distribution of lengths of the comple-
mentarity-determining region 3 (CDR3) in 2-year-old WT,
Nlrp3/, and Asc/ mice (n = 3 per group). The TCR diversity
is conferred as the result of VJ and VDJ recombinations in the
CDR3 region. Therefore, each Vb-Jb combination is represented
as a Gaussian distribution of 6–10 CDR3 lengths withup) were isolated via FACS sorting and analyzed for Il7 and Kitl (Kit ligand; stem
and Asc/mice (n = 4–6/group) was analyzed via real-time PCR analysis. The
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Figure 4. Activation of Nlrp3 Inflammasome Reduces T Cell Progenitors in Aging
(A) The thymocytes from 23-month-old WT and Nlrp3/mice (n = 4–6/group) were stained for the identification of earliest thymocyte progenitors
(LinloCD117+CD25), DN2 (LinloCD117+CD25+), and DN3 (LinloCD117CD25+) cells.
(B) There is a significant increase (p < 0.05) in the percentage of gated ETPs and DN2 cells in the thymi of aged Nlrp3/ mice.
(C) Immunoblot analysis of caspase-1 activation in the bone marrow during aging. The activated p20 active form is shown by arrow heads.
(D) Representative FACS dot plots show the analysis of MPP (LinloSca1+kit+Flt+) and CLP (LinloSca1+kitloCD127+) cells in the bone marrow of 22-month-old WT
and Nlrp3/mice. The Flt3 and CD127 expression in these subpopulation is depicted as histograms.
(E) There is a significant increase (p < 0.05) in the percentage of gated MPP cells but no change in CLPs in aged Nlrp3/ mice. (n = 6/group)consecutive addition of 3 base pairs representing in-frame rear-
rangement (Pannetier et al., 1993; Nikolich-Zugich et al.,. 2004).
As expected, in aged WT mice, TCR spectratyping revealed
severe restriction in TCR repertoire that was represented by
aberrant amplifications and deviation from a Gaussian distribu-62 Cell Reports 1, 56–68, January 26, 2012 ª2012 The Authorstion in all Vb families (Figure 5G, Figure S6). The CDR3 polymor-
phism analysis of age-matched 23-month-old Nlrp3/ and
Asc/mice revealed substantial preservation of TCR repertoire
diversity (Figures 5G and 5H; Figure S6). Collectively, these data
demonstrate that Nlrp3 inflammasome activation is a critical
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Figure 5. Ablation of the Nlrp3 Inflammasome Protects against Immune Senescence and Loss of TCR Diversity in Aging
(A) The splenocyteswere stainedwith CD4, CD8, CD62L, and CD44 for the identification of naive (CD4/CD8CD62L+CD44) and E/M (CD4/CD8CD62L+CD44)
T cells. The representative FACS dot plots from 9-month-old WT and Nlrp3/ mice are shown.
(B) 23-month-old WT and age-matched Nlrp3/ and Asc/ mice.
(C) Kinetics of CD4 and CD8 naive and E/M cells in WT and Nlrp3/ mice during aging.
(D) The quantitative PCR analysis of signal-joint TREC levels in splenic CD4+ T cells in 9- and 18-month-old WT and Nlrp3/ mice.
(E) The splenic T cells derived from 23-month-old WT and Nlrp3/mice were stimulated by plate-bound anti-CD3 and CD28 antibodies to mimic TCR ligation,
and cell growth and proliferation were measured via MTT assay.
(F) The real-time PCR analysis of Il2 mRNA from unstimulated and activated (via plate-bound anti-CD3 and CD28 antibodies) cells from 23-month-old WT and
Nlrp3/ mice.
(G and H) The TCR spectratyping analysis of CD4 T cells from 23-month-old WT and Nlrp3/ mice (n = 3/group) (G) and 23-month-old Asc/ mice (H). The
improvements in TCR diversity are depicted as landscape surfaces, in which smooth (blue) landscapes represent an unchanged TCR repertoire (diversity). The
mountain (in green, yellow, and orange) depicts the area under the curve (AUC) of Gaussian-amplified peaks of CDR3 lengths. Each line crossing on the y axis of
the landscape denotes change from WT-specific CDR3 length or size (x axis) of a particular Vb family (z axis) (n = 3/ group).mechanism for the development of T cell senescence and T cell
repertoire constriction during aging.
Elimination of Nlrp3 Inflammasome Accelerates T Cell
Reconstitution after HSCT
Age-related thymic involution is a significant impediment to
effective T cell reconstitution in middle-aged and elderly patients
who undergo HSCT as a treatment for certain cancers (Holla¨nder
et al., 2010; Williams et al., 2007; Penack et al., 2010). We per-
formed cytoablations, using a radiation dose of 750 cGy, fol-lowed by syngeneic HSCT in 2-month-old and 9-month-old
WT and Nlrp3-deficient mice to test whether the loss of Nlrp3 in-
flammasome accelerates thymic recovery and immune reconsti-
tution. In comparison to WT mice, 2-month-old Nlrp3/ mice
displayed no difference in thymic mass (Figure 6A), whereas 9-
month-old Nlrp3/ mice displayed significant increases in
thymic size and cellularity (Figures 6A–6C).
Next, we investigated whether the donor- or host-derived cells
contribute toward changes in thymic reconstitution in 2- and
9-month-old mice. There was no change in the overall numberCell Reports 1, 56–68, January 26, 2012 ª2012 The Authors 63
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Figure 6. Elimination of Nlrp3 Inflammasome Promotes T Cell Reconstitution after Irradiation and HSCT
(A) Thymic size of 2- and 9-month-old WT and Nlrp3/ mice 2 weeks after irradiation and BMT.
(B and C) Thymic weight (B) and thymocyte numbers (C) in 9-month-old WT and Nlrp3/ mice 2 weeks after 750cGy irradiation and BMT.
(D) The thymocytes from 2-month old and 8- to 9-month-old WT and Nlrp3/mice were stained with CD45.1 (for donor cells), CD45.2 (for host cells), CD4, and
CD8. The total thymocyte subset numbers gated on donor and host cells from young and middle-aged WT and Nlrp3/ mice are shown (n = 5–7). The BMT
experiments were repeated twice in two different cohorts of 8- to 9-month-old WT and Nlrp3/ mice.
(E) For the examination of cell death in WT and Nlrp3/mice undergoing irradiation and BMT, the thymocytes from 2-month-old and 8- to 9-month-old WT and
Nlrp3/ mice were stained for Annexin-V, CD45.1 (donor), and CD45.2 (host). The percentage of Annexin-V+ thymocytes from young and middle-aged WT
and Nlrp3/ mice are shown (n = 5-7).
(F) The splenocytes from 9-month-old WT and Nlrp3/mice were stained with CD3, CD62L, and CD44 for the identification of naive (CD3CD62L+CD44) and
E/M (CD3CD62L+CD44) T cells.
(G) The complete blood count (CBC) analysis in the peripheral blood of 9-month-old WT and Nlrp3/ mice 2 weeks after radiation and BMT. All data are
presented as mean ± SEM, *p < 0.05 (n = 6–8/group).of thymocyte subsets derived from host (CD45.2)- or donor
(CD45.1)-origin HSCs in 2-month-old irradiatedWT andNlrp3/
mice (Figure 6D and Figure S7A). Interestingly, by 9 months of
age, when the age-related phase of thymic involution becomes
more evident, the Nlrp3-deficient host microenvironment
afforded a significant advantage to both the donor (CD45.1) and
host (CD45.2) lineage of HSCs in their ability to reconstitute
thymic cellularity (Figure 6D and Figure S7A). Further analysis
revealed that in comparison to 2-month-old WT mice, there was64 Cell Reports 1, 56–68, January 26, 2012 ª2012 The Authorsa significant increase in thymocyte cell death (of both donor-
and host-origin cells) in 9-month-old animals (Figure 6E, Fig-
ure S7B). In young animals, Nlrp3 deficiency had no impact on
thymocyte death (Figure 6E). Interestingly, the age-related
increase in thymocyte death in both host- anddonor-lineage cells
was substantially reduced in 9-month-old Nlrp3-deficient mice
(Figure 6E and Figure S7B), suggesting that increased thymic
cellularity inNlrp3/miceafterHSCTmaybe related to reduction
in thymocytedeath. Furthermore, 9-month-oldNlrp3/micehad
a significant increase in the frequencyof naiveT cells in the spleen
2 weeks after irradiation and HSCT (Figure 6F). In addition, in
comparison to WT mice, the 9-month-old Nlrp3/ mice had
significantly (p < 0.05) higher total WBCs, lymphocyte counts,
eosinophil numbers, andhematocrit (Figure 6G) andnodifference
in the number of red blood cells, monocytes, and hemoglobin
(data not shown) in blood. Taken together, these data demon-
strate that the Nlrp3 inflammasome is a critical regulator of radia-
tion-induced injury to lymphoid organs and that ablation of Nlrp3
increases T cell reconstitution in the clinical model of HSCT.
DISCUSSION
Current approaches for lifespan extension with the goal of com-
pressing age-related morbidity draw on maintaining the function
of all organs at optimal levels. However, in middle-aged healthy
people, while the majority of other organs are functionally intact,
the thymus is largely dysfunctional. Hence, thymic aging
precedes the development of later-life immunosenescence and
age-related comorbidities, and approaches to delay thymic
aging are thought to promote a better healthspan (Dorshkind
et al., 2009). Results from human studies demonstrate that
resection of the thymus in children undergoing cardiac surgeries
accelerates immunological aging and increases IL-1b (Sauce
et al., 2009). Conversely, treatment of mice with IL-1b compro-
mises thymic function (Morrissey et al., 1988a; Morrissey et al.,
1988b). Here, we provide evidence that age-dependent Nlrp3
inflammasome activation impairs thymic lymphopoiesis by regu-
lating intrathymic caspase-1 and IL-1b. We show that age-
related increases in intrathymic ‘‘lipotoxic danger signals’’ such
as FC and ceramides cause Nlrp3 inflammasome activation
and participate in age-related thymic involution.
Nlrp3 expression is correlated with the presence of CD11b-
positive cells in the thymus, the majority of expression being
found in myeloid cells (Guarda et al., 2011). Importantly, Nlrp3
and Il1b mRNAs were found to be predominantly present in
thymic myeloid cells, whereas the IL-1b receptor was primarily
expressed in enriched TEC fractions. These findings suggest
that age-dependent inflammasome activation and production
of IL-1b from thymic macrophages or dendritic cells may
adversely impact the integrity of TEC compartment. Consistent
with these data, elimination of the Nlrp3 inflammasome in aged
mice prevented the age-related decline in cortical TECs, which
was reflected in increased levels of the TEC-derived prothymo-
poietic cytokine IL-7.
Age-related activation of intrathymic caspase-1 and IL-1b is
partly dependent on the Nlrp3 inflammasome. The aged Nlrp3-
and Asc-deficient mice had a significant increase in naive
T cells and a reduction in E/M cells. In models of peritonitis and
in vitro, the E/M T cells appear to control inflammation by
suppressing the activation of theNlrp3 inflammasomeandsecre-
tion of IL-1b (Guarda et al., 2009). Our data show that in control
aged WT mice that display increases in E/M cells, there is also
a progressive increase in Nlrp3-inflammasome-dependent cas-
pase-1 activation. These findings suggest that in aging, the
expansion of E/M T cells does not dampen Nlrp3 inflammasome
activity. Also, the T cells of aged Nlrp3-inflammasome-deficient
micedisplayedabroadTCR repertoirewith increasedexpressionof IL-2 and greater capability to proliferate in response to TCR
ligation in vitro, suggesting lower T cell senescence.
The loss of thymic cellularity and perturbations in the thymic
microenvironment are divided into phases of involution related
to development or aging (Shanley et al., 2009). The loss of thymic
cellularity is apparent after birth, and the precise mechanisms
responsible for the pre- and postpubertal reduction in thymic
cellularity and/or output versus age-related thymic involution
are not fully understood. The 1-month-old Nlrp3- and Asc-defi-
cient mice did not show any significant differences in thymic
cellularity or T cell development stages, suggesting that these
mice do not have developmental defects and that the develop-
ment-related decline in thymic cellularity is not dependent on
inflammasome activation. The early phase of loss of thymic
cellularity (which is not associated with any disease or stress)
may be a normal adaptive process, as by 1.5 or 3 months of
age in a mouse, a full repertoire of peripheral T cells is estab-
lished and homeostatic mechanisms may suppress the produc-
tion of additional T cells from the thymus. Furthermore, since the
early developmental phase is not associated with accumulation
of lipotoxic danger signals, such as FC and ceramides, the Nlrp3
inflammasome activation is relevant to regulating age-related
inflammation and thymic involution.
The thymus, in particular, undergoes massive architectural
changes with age (Dixit, 2010; Yang et al., 2009) that are associ-
ated with an age-related increase in lipid-containing cells. Aging
is also associated with an increase in several potential DAMPs
that can be sensed by inflammasomes. These activators include,
but are not limited to, oxidative-stress-associated reactive
oxygen species (ROS), mitochondrial damage, byproducts of
fatty acid oxidation, lipid peroxidation, extracellular ATP derived
from necrotic cells, or alterations in autophagy. We found that
the inflammasome was activated by increases in intracellular
FC and ceramides but not by palmitate, 4HNE, and AGE at the
concentrations used. Recent studies showed that FC crystals
that accumulate in macrophages activate the Nlrp3 inflamma-
some (Duewell et al., 2010). Themajority of cholesterol in plasma
is complexed with lipoproteins or stored in an inert-esterified
state in cell cytosol. The levels of FC in the cell membrane and
endoplasmic reticulum are tightly regulated by pathways that
control cholesterol efflux or esterification (Maxfield and Tabas,
2005). Increased levels of FC and ceramides in cells are thought
to be cytotoxic (Maxfield and Tabas, 2005). Our data suggest
that age-related accumulation of FC (before it forms the choles-
terol crystal) and ceramides in macrophages is sensed by the
Nlrp3 inflammasome andmay serve as an early proinflammatory
trigger that impairs thymic lymphopoiesis.
The loss of thymic function with age significantly delays or
compromises the establishment of a diverse T cell repertoire in
patients undergoing HSCT (Holla¨nder et al., 2010; Williams
et al., 2007). Rapid damage to thymocytes and thymic stroma
by a conditioning regimen of g-radiation is well documented
(Holland and van den Brink, 2009; Williams et al., 2007). These
data are also consistent with previous findings that IL-1b
compromises the reconstitution of the immune system after
sublethal radiation and bone marrow transplantation (Morrissey
et al., 1988a; Morrissey et al., 1988b). We found that elimination
of Nlrp3 prevented thymocyte apoptosis and accelerated theCell Reports 1, 56–68, January 26, 2012 ª2012 The Authors 65
thymic reconstitution in models of irradiation and HSCT. These
findings suggest that in patients undergoing HSCT, the current
cytoreductive clinical protocols could potentially be improved
with antiinflammatory therapy directed at blocking the Nlrp3
inflammasome and IL-1b. On the basis of our data, it is likely
that this new approach may significantly protect against thymic
injury and could potentially accelerate the reconstitution of the
T cell repertoire through increased thymic lymphopoiesis in
patients undergoing radiotherapy or HSCT.
To the best of our knowledge, our study describes a funda-
mentally new mechanism, whereby the Nlrp3 inflammasome
controls the aging of the thymus and leads to immune senes-
cence. Current studies provide conclusive evidence that thymic
aging can be substantially delayed by blocking the Nlrp3 inflam-
masome. However, an obvious caveat of aging studies in mouse
models is the maintenance of animals in a relatively calorie-
dense and sterile, pathogen-free environment. Therefore, in
current mouse models of aging, it is likely that ‘‘sterile or nonin-
fectious’’ inflammation drives several features of immunological
aging and that absence of theNlrp3 inflammasome can therefore
afford substantial protection to the thymus. Notably, the Nlrp3-
inflammasome-dependent innate immune response is required
for efficient immune response to influenza and other infections
(Pang and Iwasaki, 2011). Interestingly, early evidence suggests
that Glyburide, an Nlrp3 inflammasome and K+ (KATP) channel
blocker (Lamkanfi et al., 2009) and a widely prescribed hypogly-
cemic drug, affords substantial protection from gram-negative
sepsis in diabetic patients (Koh et al., 2011). Therefore, the
potential use of Nlrp3 inflammasome blockers or IL-1R antago-
nists such as Anakinra in age-related degenerative disorders
and thymic reconstitution deserves careful investigation. Our
findings suggest that pharmacological Nlrp3 inflammasome
blockers that specifically target the thymus may delay immuno-
senescence, maintain a diverse T cell repertoire, and enhance
immune reconstitution in elderly patients.EXPERIMENTAL PROCEDURES
Mice and Animal Care
The Asc/ and Nlrp3–/– mice have been described previously (Mariathasan
et al., 2004; Mariathasan et al., 2006). The mice were fed ad libitum with
a normal-chow diet consisting of 4.5% fat (5002; LabDiet) and aged in
specific-pathogen-free animal facility in ventilated cage racks that deliver
HEPA-filtered air to each cage. All transgenic and WT mice in our colony
were cross-fostered to our parent cohorts. The sentinel mice in our animal
rooms were negative for currently tested standard murine pathogens (ectro-
melia, epizootic diarrhea of infant mice [EDIM], lymphocytic choriomeningitis
[LCMV],Mycoplasma pulmonis, mouse hepatitis virus [MHV], murine norovirus
[MNV], mouse parvovirus [MPV], murine minute virus [MVM], pneumonia virus
of mice [PVM], reovirus type 3 [REO3], Theiler’s murine encephalomyelitis virus
[TMEV], and Sendai virus) at various times while the aging studies were per-
formed (Research Animal Diagnostic Laboratory [RADIL]).
The lethal irradiation to ablate hematopoietic cells was performed with
X-Rad300, an X-ray small animal irradiator. One week before irradiation, the
recipient mice were given acidified, antibiotic water. The lineage-depleted
bone marrow cells from CD45.1+ mice (B6.SJLPtprca Pep3b/BoyJ) were trans-
planted into irradiated (750cGy) syngeneic WT and Nlrp3–/– mice via tail vein
injection. The mice were sacrificed 2 weeks after HSCT for analysis of T cell
reconstitution. Blood was collected through cardiac puncture in EDTA-coated
vials and analyzed for complete blood counts with the automated CBC
analyzer (DxH, Beckman Coulter). All experiments were performed in compli-66 Cell Reports 1, 56–68, January 26, 2012 ª2012 The Authorsance with the NIH Guide for the Care and Use of Laboratory Animals and were
approved by the Institutional Animal Care and Use Committee of the LSU
School of Veterinary Medicine and Pennington Biomedical Research Center.
Intrathymic Injection
Mice were premedicated with atropine sulfate (0.04 mg/kg) and anesthetized
5 min later with 2% v/v isoflurane/oxygen. Mice were placed on a heating pad
in the supine position, and the trachea was intubated with a 24 gauge intrave-
nous catheter with a blunt end. Anesthesia was maintained by supplementing
oxygen (1.8 l/min) with 0.7%–2.0% isoflurane at a rate of 105/min and with
a tidal volume of 2.1–2.5 ml with the use of a rodent ventilator (Harvard Appa-
ratus). A left lateral thoracotomy was performed by blunt incision at the level of
the third intercostal space, and the left thymus was visualized with the aid of a
dissecting microscope (Zeiss) and exteriorized with forceps. Then, 50 ml of
ceramide or its vehicle, alcohol, was injected with a Hamilton syringe. The right
thymus was used as control. The left thymus was returned to the thoracic
cavity, the chest wall was closed, and the mouse was allowed to recover.
The animals were sacrificed 1 hr after intrathymic injections, and both the
left and right thymus were separated and snap frozen in liquid nitrogen and
stored in 80C until analysis of caspase-1 activation via immunoblotting.
Flow Cytometry
The ETPs and naive/memory T cell subpopulations were analyzed as previ-
ously described (Yang et al., 2009; Min et al., 2004). For LinSca1+ckit+
(LSK) cell analysis, thymocytes were stained for lineage-negative cells,
followed by staining with fluorescein isothiocyanate (FITC)-conjugated
anti-Sca1 antibody and FITC-conjugated anti-c Kit antibody (eBioscience),
then stained for Flt3 (APC). The thymocytes were stained for Annexin-V
according to the manufacturer’s instructions (eBioscience). All of the fluores-
cence-activated cell sorting (FACS) data were analyzed by postcollection
compensation using FlowJO (Treestar) software.
FC and Ceramide Measurement
For the measurement of cholesterol content in macrophages and the thymus,
the cellular lipids were extracted with isopropanol (including 5a-cholestane as
an internal standard) and kept at room temperature overnight, then analyzed
for cholesterol content by gas-liquid chromatography (GLC) as described
previously (Furbee et al., 2002). The thymic ceramide analyses were based
on studies described previously (Hammad et al., 2010). The lipids from
flash-frozen thymi were extracted via the method of Folch et al., 1957, in the
presence of 500 pmol of 12:0 ceramide as an internal standard. The ceramide
fraction was separated using 500 mg amino-SPE columns (Bodennec et al.,
2000). After concentration the samples were dissolved in 1 ml of chloroform:-
methanol (3:1 ; v/v) containing 1 mM lithium hydroxide. Ceramides were
analyzed by direct infusion at 5 ml/min into a Finnigan TSQ Discovery MAX
LC/MS/MS running in the positive ion mode. Individual ceramide species
were detected in the mixtures by the common neutral loss of 48 Da from the
lithiated ceramides.
Macrophage Culture and Cytokine Analysis
The murine BMDMs were cultured according to previously established proto-
cols (Mariathasan et al., 2006; Vandanmagsar et al., 2011). During cholesterol
loading and LPS stimulation of macrophages, BMDMs were incubated with or
without MbCD-cholesterol (final cholesterol concentration: 80 mg/ml; Sigma)
at 37C for 1 hr or with LPS for 6 hr. Then, culture supernatant was used for
quantification of IL-1b by ELISA and cells were lysed in RIPA buffer containing
complete protease inhibitor cocktail (Sigma) and used for immunoblot
analysis.
Immunoblot Analysis
We conducted the immunoblot analysis for caspase-1 and IL-1b in BMDMs,
thymus, spleen, and bone marrow as described previously (Vandanmagsar
et al., 2011). The protein immune complexes were detected with the use of
specific fluorescent secondary antibodies conjugated with IRDye 800CW
(Rockland), and membranes were imaged with the Odyssey Infrared Imaging
System or through an enhanced chemiluminescence (ECL)-based detection
method.
T Cell Proliferation
The T cells were prepared with the use of mouse negative-selection columns
(R&D Systems) and cultured on anti-CD3- and anti-CD28-coated plates (BD
Pharmingen). The proliferation was analyzed via the MTT assay in accordance
with the manufacturer’s instructions. The total RNA from unstimulated and
stimulated T cells was used for IL-2 real-time PCR analysis.
Quantitative Real-Time PCR
The total RNA from the thymus and sorted thymocytes, thymic myeloid cells
(TMCs), and enriched TECs was prepared with the use of the RNeasy Mini
Kit (QIAGEN). All samples were digested with DNase for the removal of poten-
tial genomic DNA contamination. We conducted quantitative real-time PCR as
described previously (Vandanmagsar et al., 2011).
Histology and Immunohistochemistry
The thymi obtained from mice were either fixed in 4% formalin-fixed paraffin-
embedded tissue (FFPE) or flash frozen and subsequently embedded in Ste-
phens Scientific frozen section medium and cut into 5-mm-thick cryostat
sections. At least three crysection serial sections were utilized for each stain-
ing. The FFPE sections were stainedwith hematoxylin and eosin with the use of
Autostainer (Dako), and fibrosis was analyzed by trichome staining. The frozen
sections were stained with an anti-ceramides antibody, and FC was detected
via filipin labeling. The cortical and medullary TECs were stained with uncon-
jugated rat monoclonal antibody (mAb) to TROMA-1 (DSHB, Hybridoma
Bank, University of Iowa); biotin-conjugated mouse mAb to UEA-1 (Vector
Labs) as described previously (Yang et al., 2009). Images were acquired
with a Zeiss 510 Meta multiphoton confocal microscope.
Quantification of Signal Joint T Cell Receptor Excision Circles
CD4+ T cell subsets were isolated from splenocytes with a mouse CD4+ T cell
PositiveSectionKit (Invitrogen). PCRwasperformedwithmdRec- andcJa-spe-
cificprimersandanmdReccJafluorescentprobeasdescribedpreviously (Yang
et al., 2009). The standard curves formurine TRECswere generatedwith the use
of a dRec cJa TREC PCR product cloned into a pCR-XL-TOPO plasmid.
Vb TCR Spectratyping Analysis
For TCR spectratyping and CDR3 length-analysis PCR, a FAM-labeled nested
constant b-region primer was used in combination with 24multiplexed forward
murine Vb-specific primers. PCR was performed for 35 cycles with denatur-
ation at 94C for 30 s, annealing at 55C for 30 s, and a 1 min extension at
72C, and the PCR products were analyzed on an ABI3130 Genetic Analyzer
as described previously (Yang et al., 2009; Dixit et al., 2007).
Statistical Analyses
We used a two–tailed Student’s t test to determine significance in differences
between genotypes or treatments (*p < 0.05 and p < 0.01, **p < 0.005 and
p < 0.001, respectively). We expressed the results as the mean ± SEM or
the mean ± SE. The differences between means and the effects of treatments
were also analyzed by a one–way ANOVAwith the use of a Tukey’s test (Sigma
Stat), which protects the significance (p < 0.05) of all pair combinations.
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